OMX Stockholm 30
2.512,53
PKT
-16,97
PKT
-0,67
%
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 28.03.25 | Nordea Bank Abp Registered Buy | UBS AG | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 27.03.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 27.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 27.03.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 27.03.25 | Nordea Bank Abp Registered Buy | Goldman Sachs Group Inc. | |
| 26.03.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.03.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 25.03.25 | Nordea Bank Abp Registered Underweight | JP Morgan Chase & Co. | |
| 25.03.25 | Volvo (B) Underweight | Barclays Capital | |
| 24.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 24.03.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 20.03.25 | Nordea Bank Abp Registered Buy | Goldman Sachs Group Inc. | |
| 18.03.25 | Volvo (B) Buy | Deutsche Bank AG | |
| 17.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.03.25 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 13.03.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | Nordea Bank Abp Registered Overweight | Barclays Capital | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 07.03.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 04.03.25 | AstraZeneca Outperform | Bernstein Research | |
| 03.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 28.02.25 | Volvo (B) Buy | Deutsche Bank AG | |
| 27.02.25 | Nordea Bank Abp Registered Buy | Deutsche Bank AG | |
| 27.02.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 26.02.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.